Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies

Journal of Cardiovascular Magnetic Resonance

Review

Chirine Parsai¹  Rory O’Hanlon²  Raad H Mohiaddin³  Sanjay K Prasad³ 

[1] Cardiovascular Magnetic Resonance Unit, Royal Brompton and Harefield NHS Trust, London, UK;Cardiology and CMR Unit, Polyclinique Les Fleurs, Toulon, France;Cardiovascular Magnetic Resonance Unit, Royal Brompton and Harefield NHS Trust, London, UK;Centre for Cardiovascular Magnetic Resonance, Blackrock Clinic, Dublin, Ireland;Cardiovascular Magnetic Resonance Unit, Royal Brompton and Harefield NHS Trust, London, UK;National Heart and Lung Institute, Imperial College, London, UK;

关键词: Cardiovascular Magnetic Resonance;    Aortic Stenosis;    Right Ventricle;    Late Gadolinium Enhancement;    Leave Ventricular Mass;   

DOI  :  10.1186/1532-429X-14-54

 received in 2011-10-20, accepted in 2012-07-10,  发布年份 2012

来源: Springer

【 摘 要 】

Cardiovascular Magnetic Resonance (CMR) is recognised as a valuable clinical tool which in a single scan setting can assess ventricular volumes and function, myocardial fibrosis, iron loading, flow quantification, tissue characterisation and myocardial perfusion imaging. The advent of CMR using extrinsic and intrinsic contrast-enhanced protocols for tissue characterisation have dramatically changed the non-invasive work-up of patients with suspected or known cardiomyopathy. Although the technique initially focused on the in vivo identification of myocardial necrosis through the late gadolinium enhancement (LGE) technique, recent work highlighted the ability of CMR to provide more detailed in vivo tissue characterisation to help establish a differential diagnosis of the underlying aetiology, to exclude an ischaemic substrate and to provide important prognostic markers. The potential application of CMR in the clinical approach of a patient with suspected non-ischaemic cardiomyopathy is discussed in this review.

【 授权许可】

Unknown   
© Parsai et al.; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.